Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic
Sequeira Trovao, Nidia
De Munter, Paul
Kostrikis, Leondios G.
Van Wijngaerden, Eric
Van Ranst, Marc
Van Laethem, Kristel
We aimed to study epidemic trends and predictors for transmitted drug resistance (TDR) in our region, its clinical impact and its association with transmission clusters. We included 778 patients from the AIDS Reference Center in Leuven (Belgium) diagnosed from 1998 to 2012. Resistance testing was performed using population-based sequencing and TDR was estimated using the WHO-2009 surveillance list. Phylogenetic analysis was performed using maximum likelihood and Bayesian techniques. The cohort was predominantly Belgian (58.4%), men who have sex with men (MSM) (42.8%), and chronically infected (86.5%). The overall TDR prevalence was 9.6% (95% confidence interval (CI): 7.7-11.9), 6.5% (CI: 5.0-8.5) for nucleoside reverse transcriptase inhibitors (NRTI), 2.2% (CI: 1.4-3.5) for non-NRTI (NNRTI), and 2.2% (CI: 1.4-3.5) for protease inhibitors. A significant parabolic trend of NNRTI-TDR was found (p = 0.019). Factors significantly associated with TDR in univariate analysis were male gender, Belgian origin, MSM, recent infection, transmission clusters and subtype B, while multivariate and Bayesian network analysis singled out subtype B as the most predictive factor of TDR. Subtype B was related with transmission clusters with TDR that included 42.6% of the TDR patients. Thanks to resistance testing, 83% of the patients with TDR who started therapy had undetectable viral load whereas half of the patients would likely have received a suboptimal therapy without this test. In conclusion, TDR remained stable and a NNRTI up-and-down trend was observed. While the presence of clusters with TDR is worrying, we could not identify an independent, non-sequence based predictor for TDR or transmission clusters with TDR that could help with guidelines or public health measures. © 2014 Pineda-Peña et al.
Proteinase Inhibitor ; Rna Directed Dna Polymerase Inhibitor ; Anti Human Immunodeficiency Virus Agent ; Aged ; Antiviral Resistance ; Belgium ; Cohort Analysis ; Disease Association ; Disease Surveillance ; Epidemic ; Gender ; Human ; Human Immunodeficiency Virus 1 Infection ; Human Immunodeficiency Virus Type 1 Subtype B ; Infection ; Major Clinical Study ; Male ; Men Who Have Sex With Men ; Phylogeny ; Prediction ; Prevalence ; Sequence Analysis ; Transmitted Drug Resistance ; Trend Study ; Virus Load ; Virus Transmission ; Antiviral Resistance ; Cluster Analysis ; Drug Effects ; Genetics ; Genotype ; Health Survey ; Hiv Infections ; Human Immunodeficiency Virus 1 ; Microbial Sensitivity Test ; Pregnancy ; Retrospective Study ; Risk Factor ; Transmission ; Virology ; Young Adult ; Aged ; Anti-Hiv Agents ; Belgium ; Cluster Analysis ; Drug Resistance, Viral ; Genotype ; Hiv Infections ; Hiv-1 ; Male ; Microbial Sensitivity Tests ; Pregnancy ; Prevalence ; Public Health Surveillance ; Young Adult ;
- Artículos 
Showing items related by title, author, creator and subject.
"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral" Delang, Leen; Guerrero, Nidya Segura; Tas, Ali; Quérat, Gilles; Pastorino, Boris; Froeyen, Mathy; Dallmeier, Kai; Jochmans, Dirk; Herdewijn, Piet; Bello, Felio; Snijder, Eric J.; de Lamballerie, Xavier; Martina, Byron; Neyts, Johan; van Hemert, Martijn J.; Leyssen, Pieter"Objectives: T-705, also known as favipiravir, is a small-molecule inhibitor that is currently in clinical development for the treatment of influenza virus infections. This molecule also inhibits the replication of a broad ...Artículo. 2014
Classical molecular tests using urine samples as a potential screening tool for human papillomavirus detection in human immunodeficiency virus-infected women Munoz, Marina; Camargo, Milena; Leon, Sara C. Soto-De; Sanchez, Ricardo; Pineda-Peña, Andrea C.; Perez-Prados, Antonio; Patarroyo, Manuel E.; Patarroyo, Manuel A."Human papillomavirus (HPV) is the main risk factor associated with the development of cervical cancer (CC); however, there are other factors, such as immunosuppression caused by the human immunodeficiency virus (HIV), ...Artículo. 2013
Human papillomavirus detection from human immunodeficiency virus-infected colombian women's paired urine and cervical samples Munoz, Marina; Camargo, Milena; Soto De Leon, Sara C; Sánchez, Ricardo; Parra, Diana; Pineda, Andrea C.; Sussmann, Otto; Perez-Prados, Antonio; Patarroyo, Manuel E.; Patarroyo, Manuel A.Infection, coinfection and type-specific human papillomavirus (HPV) distribution was evaluated in human immunodeficiency virus (HIV)-positive women from paired cervical and urine samples. Paired cervical and urine samples ...Artículo. 2013